arrow
W

Wen-Ling Kuo

cogent biosciences
H指数:19
被引数:1,461

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TPRG-05 A FIRST-IN-HUMAN STUDY OF A CNS-PENETRANT, SELECTIVE ERBB2 INHIBITOR, CGT4255, IN PATIENTS WHO HAVE ADVANCED SOLID TUMORS WITH ERRB2 GENETIC ALTERATIONS OR HER2 OVEREXPRESSION

TPRG-05 CGT4255作为中枢神经系统穿透性、选择性ERBB2抑制剂在具有ERBB2基因改变或HER2过表达的晚期实体瘤患者中的首次人体研究

2026-08-070
OA
Efficacy and safety of luspatercept in non-transfusion-dependent β-thalassemia: long-term results from the BEYOND study

luspaterecpt 在非输血依赖性β-地中海贫血中的有效性和安全性:BEYOND研究的长期能力结果

2025-09-010
OAAI
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial
2022-10-0131
PRE
Vitamin E Enhances Cancer Immunotherapy by Reinvigorating Dendritic Cells via Targeting Checkpoint SHP1

维生素e通过靶向检查点SHP1重新激活树突状细胞来增强癌症免疫治疗

2022-04-1458
OA